KINSHASA (Reuters) – The first batch of 4,000 experimental Ebola vaccines to combat an outbreak suspected to have killed 20 people arrived in Congo‘s capital Kinshasa on Wednesday. That is the first time the vaccine would come into use since it was developed two years ago. The vaccine, developed by Merck and sent from Europe by...